Kometer, Michael

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

Vollenweider, F. X., & Kometer, M. (2010) · Nature Reviews Neuroscience

Psychedelics and Drug StudiesNeurotransmitter Receptor Influence on Behavior

Cited by 723

Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies

Studerus, E., Kometer, M., Hasler, F., & Vollenweider, F. X. (2011) · Journal of Psychopharmacology

Psychedelics and Drug StudiesParanormal Experiences and Beliefs

Cited by 532

Prediction of Psilocybin Response in Healthy Volunteers

Studerus, E., Gamma, A., Kometer, M., & Vollenweider, F. X. (2012) · PLoS ONE

Psychedelics and Drug StudiesParanormal Experiences and Beliefs

Cited by 369

Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations

Kometer, M., Schmidt, A., Jancke, L., & Vollenweider, F. X. (2013) · Journal of Neuroscience

Psychedelics and Drug StudiesHallucinations in medical conditions

Cited by 355

Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors

Kometer, M., Schmidt, A., Bachmann, R., Studerus, E., Seifritz, E., & Vollenweider, F. X. (2012) · Biological Psychiatry

Psychedelics and Drug StudiesNeurotransmitter Receptor Influence on Behavior

Cited by 298

Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects

Smigielski, L., Scheidegger, M., Kometer, M., & Vollenweider, F. X. (2019) · NeuroImage

Psychedelics and Drug StudiesParanormal Experiences and Beliefs

Cited by 248

Effect of Psilocybin on Empathy and Moral Decision-Making

Pokorny, T., Preller, K. H., Kometer, M., Dziobek, I., & Vollenweider, F. X. (2017) · International Journal of Neuropsychopharmacology

Psychedelics and Drug StudiesNeurotransmitter Receptor Influence on Behavior

Cited by 197

Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat

Smigielski, L., Kometer, M., Scheidegger, M., Krähenmann, R., Huber, T., & Vollenweider, F. X. (2019) · Scientific Reports

Psychedelics and Drug StudiesParanormal Experiences and Beliefs

Cited by 176

Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments

Schmidt, A., Bachmann, R., Kometer, M., Csomor, P. A., Stephan, K. E., Seifritz, E., & Vollenweider, F. X. (2012) · Neuropsychopharmacology

Psychedelics and Drug StudiesSchizophrenia research and treatment

Cited by 121

Modeling ketamine effects on synaptic plasticity during the mismatch negativity

Schmidt, A., Diaconescu, A. O., Kometer, M., Friston, K. J., Stephan, K. E., & Vollenweider, F. X. (2013) · Cerebral Cortex

Neural dynamics and brain functionNeuroscience and Music Perception

Cited by 109

Overcoming the clinical challenges of traditional ayahuasca: a first-in-human trial exploring novel routes of administration of N,N-dimethyltryptamine and harmine

Dornbierer, D. A., Marten, L., Mueller, J., Aicher, H. D., Mueller, M. J., Boxler, M., Kometer, M., Kosanic, D., von Rotz, R., Puchkov, M., et al. (2023) · Frontiers in Pharmacology

Psychedelics and Drug StudiesAlkaloids: synthesis and pharmacology

Cited by 32